-
EP2986603
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2986603
| EP2986603 - RADIOLABELED GNRH ANTAGONISTS AS PET IMAGING AGENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 06.04.2018 Database last updated on 22.05.2024 | |
| Former | Examination is in progress Status updated on 10.02.2017 | Most recent event Tooltip | 06.04.2018 | Application deemed to be withdrawn | published on 09.05.2018 [2018/19] | Applicant(s) | For all designated states Oslo Universitetssykehus HF Postboks 450 Nydalen 0424 Oslo / NO | [2016/08] | Inventor(s) | 01 /
OLBERG, Dag, Erlend p/a Oslo Universitetssykehus HF Postboks 450 0424 NYDALEN, OSLO / NO | 02 /
HARALDSEN, Ira, Hebold Holmenveien 35b 0374 Oslo / NO | 03 /
KLAVENESS, Jo Midtåsen 5 1166 Oslo / NO | [N/P] |
| Former [2016/08] | 01 /
OLBERG, Dag, Erlend Bård Skolemesters Vei 8 0590 Oslo / NO | ||
| 02 /
HARALDSEN, Ira, Hebold Holmenveien 35b 0374 Oslo / NO | |||
| 03 /
KLAVENESS, Jo Midtåsen 5 1166 Oslo / NO | Representative(s) | Algemeen Octrooi- en Merkenbureau B.V. P.O. Box 645 5600 AP Eindhoven / NL | [2016/08] | Application number, filing date | 14771618.7 | 18.04.2014 | [2016/08] | WO2014IB01726 | Priority number, date | US201361813756P | 19.04.2013 Original published format: US 201361813756 P | [2016/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014184682 | Date: | 20.11.2014 | Language: | EN | [2014/47] | Type: | A1 Application with search report | No.: | EP2986603 | Date: | 24.02.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.11.2014 takes the place of the publication of the European patent application. | [2016/08] | Search report(s) | International search report - published on: | EP | 20.11.2014 | Classification | IPC: | C07D405/12, A61K51/04, C07B59/00, C07D307/68 | [2016/08] | CPC: |
A61K51/0459 (EP,US);
A61K51/0419 (EP,US);
C07B59/002 (EP,US);
C07D307/68 (EP,US);
C07D405/12 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/08] | Title | German: | RADIOAKTIV MARKIERTE GNRH-ANTAGONISTEN ALS PET-KONTRASTMITTEL | [2016/08] | English: | RADIOLABELED GNRH ANTAGONISTS AS PET IMAGING AGENTS | [2016/08] | French: | ANTAGONISTES DE LA GONADOTROPHINE (GNRH) RADIOMARQUÉS UTILISÉS COMME AGENTS D'IMAGERIE PAR TOMOGRAPHIE PAR ÉMISSION DE POSITRONS (TEP) | [2016/08] | Entry into regional phase | 17.11.2015 | National basic fee paid | 17.11.2015 | Designation fee(s) paid | 17.11.2015 | Examination fee paid | Examination procedure | 17.11.2015 | Amendment by applicant (claims and/or description) | 17.11.2015 | Examination requested [2016/08] | 14.10.2016 | Despatch of a communication from the examining division (Time limit: M06) | 21.04.2017 | Reply to a communication from the examining division | 17.05.2017 | Despatch of a communication from the examining division (Time limit: M06) | 28.11.2017 | Application deemed to be withdrawn, date of legal effect [2018/19] | 04.01.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/19] | Fees paid | Renewal fee | 27.04.2016 | Renewal fee patent year 03 | 27.04.2017 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO02098363 (AGOURON PHARMA [US], et al) [Y] 1-21 * claim 1 *; | [Y]WO03068769 (PFIZER [US], et al) [Y] 1-21 * claim 1 *; | [XPI] - OLBERG D. E. ET AL., "Synthesis and in vitro evaluation of small-molecule [18F] labeled gonadotropin-releasing hormone (GnRH) receptor antagonists as potential PET imaging agents for GnRH receptor expression", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, (20140210), vol. 24, pages 1846 - 1850, XP002731249 [XP] 1-21 * scheme 3 * [I] 1-21 DOI: http://dx.doi.org/10.1016/j.bmcl.2014.02.002 | [Y] - MILLER PHILIP W ET AL, "Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, (20080101), vol. 47, no. 47, doi:10.1002/ANIE.200800222, ISSN 1433-7851, pages 8998 - 9033, XP002609759 [Y] 1-21 * the whole document * DOI: http://dx.doi.org/10.1002/ANIE.200800222 | by applicant | US6674083 | US6822240 | US4864138 | US5451789 | US5453623 | US4584187 | US4622217 | WO2011094186 | - LIPINSKI ET AL., "Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings", ADVDRUG LIVREV, (1997), vol. 23, doi:doi:10.1016/S0169-409X(96)00423-1, pages 3 - 25, XP000892390 DOI: http://dx.doi.org/10.1016/S0169-409X(96)00423-1 | - SHEPP ET AL., IEEE TRANS. MED. IMAGING, (1982), vol. 2, pages 113 - 122 | - LANGE ET AL., J. COMPUT. ASSIST. TOMOGR., (1984), vol. 8, pages 306 - 316 | - KLINE ET AL., "Myocardial Imaging in Man with [123 I]-Meta-Iodobenzylguanidine", J. NUCL. MED., (1981), vol. 22, pages 129 - 132, XP001478341 | - WIELAND ET AL., "Myocardial Imaging with a Radioiodinated Norepinephrine Storage Analog", J. NUCL. MED., (1981), vol. 22, pages 22 - 31 | - VALK ET AL., "Spectrum of Pheochromocytoma in Multiple Endocrine Neoplasia: A Scintigraphic Portrayal Using .sup.131 I-Meta-Iodobenzylguanidine", ANN. INTERN. MED., (1981), vol. 94, pages 762 - 767 | - SISSON ET AL., "Scintigraphic Localization of Pheochromocytoma", NEW ENG. J. MED., (1981), vol. 305, pages 12 - 17 | - LYNN ET AL., "Portrayal of Pheochromocytoma and Normal Human Adrenal Medulla by m-[I-123]-iodobenzylguanidine", J. NUCL. MED., (1984), vol. 25, 436- | - LI ET AL., J MED CHEM, (2006), vol. 49, pages 3362 - 3367 | - KROBERT ET AL., "The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution", NAUNYN SCHMIEDEBEIGSARCH PHARMACOL, (2001), vol. 363, no. 6, pages 620 - 32 | - PARLOW JJ, "Selective syntheses of substituted 6-alkyl-1,1-dimethyl-1,2,3,4-tetrahydronaphthalenes", TETRAHEDON, (1993), vol. 49, pages 2577 - 2588 |